
Feb 19 (Reuters) - Nkgen Biotech Inc NKGN.O:
NKGEN APPOINTS DR. ANITA FLETCHER AS NATIONAL PRINCIPAL INVESTIGATOR FOR PHASE 2A TROCULEUCEL TRIAL EVALUATING MODERATE ALZHEIMER’S DISEASE WITH ADVENTHEALTH ORLANDO AS FIRST EAST COAST SITE
Source text: ID:nGNX9pTy5b
Further company coverage: NKGN.O